MedPath

Research about the onset mechanism of the gastric cancer after the antimicrobial treatment for Helicobacter pylori.

Not Applicable
Conditions
Gstric cancer and chronic gastritis after the Helicobacter pylori antimicrobial treatment
Registration Number
JPRN-UMIN000027524
Lead Sponsor
Kawasaki Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria are history of gastrectomy, and patients with gastric cancer or other malignant lesions, pylori-positive,hemorrhagic diseases, cirrhosis or renal failure.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The gene expression causing the map-like redness and a background gastric mucosa associated with the second cancer outbreak after the Helicobacter pylori antimicrobial treatment.
Secondary Outcome Measures
NameTimeMethod
ew biomarkers associated with the second cancer outbreak after the Helicobacter pylori antimicrobial treatment.
© Copyright 2025. All Rights Reserved by MedPath